Asston Pharma Appoints M/s Panchal S K & Associates as Statutory Auditors

Asston Pharmaceuticals Ltd announced the appointment of M/s Panchal S K & Associates as the company's Statutory Auditors. This approval was granted by the company's members during the 7th Annual General Meeting held on September 29, 2026. The resolution also included the adoption of audited standalone financial statements for the financial year ended March 31, 2026, and the re-appointment of Mr. Ashish Narayan Sakalkar as Managing Director. Additionally, increases in remuneration for Mr. Ashish Narayan Sakalkar, Mrs. Saili Jayaram More (Whole-time Director and CEO), and Mr. Sachin Chandrakant Badakh (Non-Executive Director) were approved.